Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
NPY5R Blocking Peptide (AC1321)
Cat.#: ACPP-1321
Specifications
Despition NPY5R Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1322 TRPM8 Blocking Peptide (AC1322) 250 µg inquiry ACPP-1070 Human Neuron Specific Enolase (Active) (AC1070) 100 µg inquiry ACPP-1344 Olig2 Blocking Peptide (AC1344) 250 µg inquiry ACPP-1749 Human CSNK1D Protein (AC1749) 5 µg inquiry ACPP-1149 Recombinant Human TNF Receptor II Protein (Fc Tag) (AC1149) 50 µg inquiry ACPP-1447 Human CANX Protein (AC1447) 10 µg inquiry ACPP-1242 MC3 Receptor Blocking Peptide (AC1242) 250 µg inquiry ACPP-1368 KCNJ2 Blocking Peptide (AC1368) 250 µg inquiry ACPP-1081 Human NRN1 Protein (AC1081) 5 µg inquiry ACPP-1453 Human ACOT7 Protein (AC1453) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket